Hong Kong-listed Biostime has won the auction for vitamin maker Swisse Wellness for $1.67 billion, sources said on Thursday.
Biostime, advised by HSBC, trumped a field including Chinese private equity firm Hony Capital and Chinese drug manufacturer Shanghai Pharma in the Goldman Sachs-run sale.
Loading...
Sarah Thompson has co-edited Street Talk since 2009, specialising in private equity, investment banking, M&A and equity capital markets stories. Prior to that, she spent 10 years in London as a markets and M&A reporter at Bloomberg and Dow Jones. Email Sarah at sarah.thompson@afr.com
Anthony Macdonald is a Chanticleer columnist. He is a former Street Talk co-editor and has 10 years' experience as a business journalist and worked at PwC, auditing and advising financial services companies. Connect with Anthony on Twitter. Email Anthony at a.macdonald@afr.com
